Related Experiment Video

Updated: Aug 26, 2026

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture
03:42

Growing Desmoplastic Three-Dimensional Pancreatic Cancer Spheroids from Co-Culture

Published on: September 27, 2024

Alterations of cell signaling pathways in pancreatic cancer

James W Freeman1, Daniel DeArmond, Michael Lake

  • 1Department of Medicine, Division of Medical Oncology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, Texas 78229-3900, USA. freemanjw@uthscsa.edu

Frontiers in Bioscience : a Journal and Virtual Library
|February 24, 2004
PubMed

Insights

Pancreatic cancer has a poor prognosis. Identifying new biological targets and understanding cell signaling pathways, like TGF beta and phosphotyrosine kinase receptors, are key to developing novel pancreatic cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling

Background:

  • Pancreatic ductal adenocarcinomas exhibit a dismal five-year survival rate below 4%.
  • Improving patient survival necessitates identifying novel biological targets driving pancreatic cancer's aggressive nature.
  • Understanding aberrant cell signaling pathways is crucial for developing effective pancreatic cancer treatments.

Purpose of the Study:

  • To review key cell signaling pathways implicated in pancreatic cancer biology.
  • To discuss the dual role of Transforming Growth Factor beta (TGF-β) signaling in tumor suppression and promotion.
  • To examine the impact of deregulated phosphotyrosine kinase receptor signaling in pancreatic cancer.

Main Methods:

  • Literature review of pancreatic cancer signaling pathways.
  • Analysis of studies focusing on TGF-β signaling.
  • Review of research on phosphotyrosine kinase receptor signaling.

Main Results:

  • TGF-β signaling demonstrates context-dependent roles in pancreatic cancer, acting as both a tumor suppressor and promoter.
  • Deregulation of phosphotyrosine kinase receptor signaling pathways is frequently observed in pancreatic cancer.
  • These pathways significantly influence pancreatic cancer's aggressive phenotype and therapeutic response.

Conclusions:

  • Targeting specific cell signaling pathways holds promise for improving pancreatic cancer patient outcomes.
  • Further research into TGF-β and phosphotyrosine kinase receptor signaling is warranted for therapeutic development.
  • Comprehensive understanding of these pathways can lead to more effective pancreatic cancer interventions.

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...